IM
Immunome, Inc.
IMNM · NASDAQ
$23.93 -0.71% (-$0.17)
1M -21.35%
Market Cap $2.29B
P/E Ratio -
Div. Yield -
ROE 50.56%
Piotroski F-Score Weak
2/9Valuation
46 /100
Fair P/B 4.36x
P/E N/A
EV/EBITDA N/A
Growth
100 /100
Growing Book val. growth 236.47%
EPS growth N/A
Rev. growth N/A
Profitability
-
N/A Gross margin N/A
Net margin N/A
Op. margin N/A
Quality
0 /100
Poor ROIC 51.06%
ROE 50.56%
ROA 44.98%
Debt
100 /100
Low Debt/Equity 0.01x
Current ratio 15.08x
Int. coverage N/A
Stability
10 /100
Unstable Beta 2.13x
EPS volatility 63.65%
Profitable years 0
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about IMNM
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Clay Siegall
Employees
247
Headquarters
Bothell
Upcoming events
05 NOV
Earnings
Upcoming earnings report